Selected research
Industry Research
Erdosteine Industry Research Report 2026
Market perspective
The global Erdosteine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Erdosteine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Erdosteine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Erdosteine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Erdosteine include Zhejiang Kangle Pharmaceutical, Shanghai Pukang Pharmaceuticals, Wuhan Yuancheng Pharmaceutical, Edmond Pharma and Alitair Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Erdosteine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Erdosteine Market by Company
Zhejiang Kangle Pharmaceutical
Shanghai Pukang Pharmaceuticals
Wuhan Yuancheng Pharmaceutical
Edmond Pharma
Alitair Pharmaceuticals
Erdosteine Segment by Type
Tablets
Capsules
Erdosteine Segment by Application
Bronchitis
Nasopharyngitis
Others
Erdosteine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erdosteine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Erdosteine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erdosteine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Erdosteine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Erdosteine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Erdosteine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Bronchitis
- Nasopharyngitis
- Others
Companies covered
- Zhejiang Kangle Pharmaceutical
- Shanghai Pukang Pharmaceuticals
- Wuhan Yuancheng Pharmaceutical
- Edmond Pharma
- Alitair Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Erdosteine Market Size (2021-2032)
- 2.2.2 Global Erdosteine Sales (2021-2032)
- 2.2.3 Global Erdosteine Market Average Price (2021-2032)
- 2.3 Erdosteine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.4 Erdosteine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Bronchitis
- 2.4.3 Nasopharyngitis
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Erdosteine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Erdosteine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Erdosteine Revenue of Manufacturers (2021-2026)
- 3.4 Global Erdosteine Average Price by Manufacturers (2021-2026)
- 3.5 Global Erdosteine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Erdosteine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Erdosteine, Product Type & Application
- 3.8 Global Manufacturers of Erdosteine, Established Date
- 3.9 Global Erdosteine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Kangle Pharmaceutical
- 4.1.1 Zhejiang Kangle Pharmaceutical Company Information
- 4.1.2 Zhejiang Kangle Pharmaceutical Business Overview
- 4.1.3 Zhejiang Kangle Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Kangle Pharmaceutical Erdosteine Product Portfolio
- 4.1.5 Zhejiang Kangle Pharmaceutical Recent Developments
- 4.2 Shanghai Pukang Pharmaceuticals
- 4.2.1 Shanghai Pukang Pharmaceuticals Company Information
- 4.2.2 Shanghai Pukang Pharmaceuticals Business Overview
- 4.2.3 Shanghai Pukang Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Pukang Pharmaceuticals Erdosteine Product Portfolio
- 4.2.5 Shanghai Pukang Pharmaceuticals Recent Developments
- 4.3 Wuhan Yuancheng Pharmaceutical
- 4.3.1 Wuhan Yuancheng Pharmaceutical Company Information
- 4.3.2 Wuhan Yuancheng Pharmaceutical Business Overview
- 4.3.3 Wuhan Yuancheng Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wuhan Yuancheng Pharmaceutical Erdosteine Product Portfolio
- 4.3.5 Wuhan Yuancheng Pharmaceutical Recent Developments
- 4.4 Edmond Pharma
- 4.4.1 Edmond Pharma Company Information
- 4.4.2 Edmond Pharma Business Overview
- 4.4.3 Edmond Pharma Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Edmond Pharma Erdosteine Product Portfolio
- 4.4.5 Edmond Pharma Recent Developments
- 4.5 Alitair Pharmaceuticals
- 4.5.1 Alitair Pharmaceuticals Company Information
- 4.5.2 Alitair Pharmaceuticals Business Overview
- 4.5.3 Alitair Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Alitair Pharmaceuticals Erdosteine Product Portfolio
- 4.5.5 Alitair Pharmaceuticals Recent Developments
5 Global Erdosteine Market Scenario by Region
- 5.1 Global Erdosteine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Erdosteine Sales by Region: 2021-2032
- 5.2.1 Global Erdosteine Sales by Region: 2021-2026
- 5.2.2 Global Erdosteine Sales by Region: 2027-2032
- 5.3 Global Erdosteine Revenue by Region: 2021-2032
- 5.3.1 Global Erdosteine Revenue by Region: 2021-2026
- 5.3.2 Global Erdosteine Revenue by Region: 2027-2032
- 5.4 North America Erdosteine Market Facts & Figures by Country
- 5.4.1 North America Erdosteine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Erdosteine Sales by Country (2021-2032)
- 5.4.3 North America Erdosteine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Erdosteine Market Facts & Figures by Country
- 5.5.1 Europe Erdosteine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Erdosteine Sales by Country (2021-2032)
- 5.5.3 Europe Erdosteine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Erdosteine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Erdosteine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Erdosteine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Erdosteine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Erdosteine Market Facts & Figures by Country
- 5.7.1 South America Erdosteine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Erdosteine Sales by Country (2021-2032)
- 5.7.3 South America Erdosteine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Erdosteine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Erdosteine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Erdosteine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Erdosteine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Erdosteine Sales by Type (2021-2032)
- 6.1.1 Global Erdosteine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Erdosteine Sales Market Share by Type (2021-2032)
- 6.2 Global Erdosteine Revenue by Type (2021-2032)
- 6.2.1 Global Erdosteine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Erdosteine Revenue Market Share by Type (2021-2032)
- 6.3 Global Erdosteine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Erdosteine Sales by Application (2021-2032)
- 7.1.1 Global Erdosteine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Erdosteine Sales Market Share by Application (2021-2032)
- 7.2 Global Erdosteine Revenue by Application (2021-2032)
- 7.2.1 Global Erdosteine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Erdosteine Revenue Market Share by Application (2021-2032)
- 7.3 Global Erdosteine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Erdosteine Value Chain Analysis
- 8.1.1 Erdosteine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Erdosteine Production Mode & Process
- 8.2 Erdosteine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Erdosteine Distributors
- 8.2.3 Erdosteine Customers
9 Global Erdosteine Analyzing Market Dynamics
- 9.1 Erdosteine Industry Trends
- 9.2 Erdosteine Industry Drivers
- 9.3 Erdosteine Industry Opportunities and Challenges
- 9.4 Erdosteine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst